304 related articles for article (PubMed ID: 1715686)
21. Specific inhibition of insulin receptor dephosphorylation by a synthetic dodecapeptide containing sulfotyrosyl residues as phosphotyrosyl mimetic.
Kole HK; Liotta AS; Garant MJ; Kole S; Bernier M
Indian J Biochem Biophys; 1997; 34(1-2):50-5. PubMed ID: 9343928
[TBL] [Abstract][Full Text] [Related]
22. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.
Meyerovitch J; Backer JM; Kahn CR
J Clin Invest; 1989 Sep; 84(3):976-83. PubMed ID: 2547842
[TBL] [Abstract][Full Text] [Related]
23. Protein-tyrosine phosphatases and the regulation of insulin action.
Goldstein BJ
J Cell Biochem; 1992 Jan; 48(1):33-42. PubMed ID: 1316360
[TBL] [Abstract][Full Text] [Related]
24. Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C.
Tomic S; Greiser U; Lammers R; Kharitonenkov A; Imyanitov E; Ullrich A; Böhmer FD
J Biol Chem; 1995 Sep; 270(36):21277-84. PubMed ID: 7673163
[TBL] [Abstract][Full Text] [Related]
25. CD45, an integral membrane protein tyrosine phosphatase. Characterization of enzyme activity.
Tonks NK; Diltz CD; Fischer EH
J Biol Chem; 1990 Jun; 265(18):10674-80. PubMed ID: 2162357
[TBL] [Abstract][Full Text] [Related]
26. Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin.
Bandyopadhyay D; Kusari A; Kenner KA; Liu F; Chernoff J; Gustafson TA; Kusari J
J Biol Chem; 1997 Jan; 272(3):1639-45. PubMed ID: 8999839
[TBL] [Abstract][Full Text] [Related]
27. NMR analysis of regioselectivity in dephosphorylation of a triphosphotyrosyl dodecapeptide autophosphorylation site of the insulin receptor by a catalytic fragment of LAR phosphotyrosine phosphatase.
Lee JP; Cho H; Bannwarth W; Kitas EA; Walsh CT
Protein Sci; 1992 Oct; 1(10):1353-62. PubMed ID: 1303753
[TBL] [Abstract][Full Text] [Related]
28. Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation.
Goldstein BJ
Receptor; 1993; 3(1):1-15. PubMed ID: 8394171
[TBL] [Abstract][Full Text] [Related]
29. Purification and characterization of a higher-molecular-mass form of protein phosphotyrosine phosphatase (PTP 1B) from placental membranes.
Pallen CJ; Lai DS; Chia HP; Boulet I; Tong PH
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):315-23. PubMed ID: 1646596
[TBL] [Abstract][Full Text] [Related]
30. Insulin differentially regulates protein phosphotyrosine phosphatase activity in rat hepatoma cells.
Meyerovitch J; Backer JM; Csermely P; Shoelson SE; Kahn CR
Biochemistry; 1992 Oct; 31(42):10338-44. PubMed ID: 1420153
[TBL] [Abstract][Full Text] [Related]
31. Effect of microinjection of a low-Mr human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes.
Tonks NK; Cicirelli MF; Diltz CD; Krebs EG; Fischer EH
Mol Cell Biol; 1990 Feb; 10(2):458-63. PubMed ID: 2153916
[TBL] [Abstract][Full Text] [Related]
32. The epidermal growth factor receptor from prostate cells is dephosphorylated by a prostate-specific phosphotyrosyl phosphatase.
Lin MF; Clinton GM
Mol Cell Biol; 1988 Dec; 8(12):5477-85. PubMed ID: 2854198
[TBL] [Abstract][Full Text] [Related]
33. Assay of phosphotyrosyl protein phosphatase using synthetic peptide 1142-1153 of the insulin receptor.
King MJ; Sale GJ
FEBS Lett; 1988 Sep; 237(1-2):137-40. PubMed ID: 2844584
[TBL] [Abstract][Full Text] [Related]
34. Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes.
Cicirelli MF; Tonks NK; Diltz CD; Weiel JE; Fischer EH; Krebs EG
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5514-8. PubMed ID: 2164686
[TBL] [Abstract][Full Text] [Related]
35. Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus.
Meyerovitch J; Rothenberg P; Shechter Y; Bonner-Weir S; Kahn CR
J Clin Invest; 1991 Apr; 87(4):1286-94. PubMed ID: 1707061
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning and expression of a unique receptor-like protein-tyrosine-phosphatase in the leucocyte-common-antigen-related phosphate family.
Zhang WR; Hashimoto N; Ahmad F; Ding W; Goldstein BJ
Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):39-47. PubMed ID: 8068021
[TBL] [Abstract][Full Text] [Related]
37. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.
Ahmad F; Considine RV; Goldstein BJ
J Clin Invest; 1995 Jun; 95(6):2806-12. PubMed ID: 7769120
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the major protein-tyrosine-phosphatases of human placenta.
Tonks NK; Diltz CD; Fischer EH
J Biol Chem; 1988 May; 263(14):6731-7. PubMed ID: 2834387
[TBL] [Abstract][Full Text] [Related]
39. Substrate specificity of the protein tyrosine phosphatases.
Zhang ZY; Thieme-Sefler AM; Maclean D; McNamara DJ; Dobrusin EM; Sawyer TK; Dixon JE
Proc Natl Acad Sci U S A; 1993 May; 90(10):4446-50. PubMed ID: 7685104
[TBL] [Abstract][Full Text] [Related]
40. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.
Ahmad F; Azevedo JL; Cortright R; Dohm GL; Goldstein BJ
J Clin Invest; 1997 Jul; 100(2):449-58. PubMed ID: 9218523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
